Conference Proceedings

Patients' and their doctors' preferences for adjuvant sorafenib after resection of intermediate to high risk RCC: what makes it worthwhile?

S Sengupta, P Blinman, J Thompson, T France, A Martin, I Davis, M Stockler

BJU International | WILEY-BLACKWELL | Published : 2013